Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F5U5W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,620
Award facts
- Contract value 100% obligated
- $29,620.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Cosentyx (secukinumab) 300 mg dose in 2 pens per milliliter formulation, with a ceiling value of $29,620.11. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract calls for completion by December 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency encompasses a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. This award for Cosentyx, a specialty biologic medication used to treat inflammatory conditions, reflects AmerisourceBergen's role in supplying specialized pharmaceuticals to support the Defense Health Agency and broader military healthcare requirements through the DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F5U5W?
SPE2DR26F5U5W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F5U5W worth?
The government has obligated $29,620 on SPE2DR26F5U5W.
Is contract SPE2DR26F5U5W an order under another contract?
Yes. SPE2DR26F5U5W is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F5U5W competed?
The extent of competition for SPE2DR26F5U5W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award